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This flu season has been especially bad. As 
of epidemiological week 4 (week ending on 
January 27th), overall hospitalizations are 
now the highest we’ve seen in recent years 
and flu associated deaths in children and 
adults continue to be reported. According to 
the Centers for Disease Control and 
Prevention (CDC), latest tracking data 
indicate that the flu activity is still high and 
widespread across most of the nation and 
increasing overall. Influenza A H3N2 
continues to dominate this season, but H1N1 
and influenza B are also causing illness.  
 
WHAT YOU CAN DO AS A 
HOSPITALIST: 
Recommend influenza vaccination: It is not 
too late to get the vaccine. Even though most 
flu vaccines have low effectiveness against 
H3N2 viruses, the effectiveness against other 
flu viruses is better, and there is more than 
one flu virus circulating this season. The 
vaccine may also reduce the severity of 
symptoms if you acquire the flu despite being 
vaccinated.  
 
Recommend pneumococcal vaccination: 
Some of the serious consequences of 
influenza are bacterial pneumonias. 
Indications for vaccination include: age 65 or 
older, functional or anatomic asplenia, 
cerebrospinal fluid (CSF) leaks, cochlear 
implants, immunocompromising conditions.  
                                                               
Practice and teach the following: Stay 
home if you are sick to help prevent 
spreading respiratory viruses to others, 
frequently wash your hands, and cover your 
mouth when you cough or sneeze.  
 
Use antivirals (neuraminidase inhibitors): 
Treatment with neuraminidase inhibitors has 
been shown to have clinical and public health 
benefit in reducing illness and severe 
outcomes of influenza. Any hospitalized 
patient, those with severe illness or at risk of 
developing serious complications (people 65 
and older, pregnant women, young children, 
people with heart or lung disease) should be 
treated as soon as possible with antiviral 
medications. Ideally, treatment should be 
initiated within 48 hours of symptom onset. 
However, antiviral treatment initiated later 
than 48 hours after illness onset can still be 
beneficial for some patients. Because of the 
importance of early treatment, decisions 
about starting antiviral treatment should not 
wait for laboratory confirmation of influenza. 
 
Notes 
Financial support: Author declares that no financial 
assistance was taken from any source. 
Potential conflicts of interest: Author declares no 
conflicts of interest. Author declares that he has no 
commercial or proprietary interest in any drug, device, 
or equipment mentioned in the submitted article.  
 
Reference  
1. CDC. (2018, February 9). Influenza (flu) including 
seasonal, avian, swine, pandemic, and other. 
Retrieved from https://www.cdc.gov/flu/index.htm 
